Centers for Disease Control and Prevention, Division of Viral Diseases, Atlanta, GA, United States.
Department of Dermatology, Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, RI, United States.
Front Immunol. 2021 Dec 20;12:796065. doi: 10.3389/fimmu.2021.796065. eCollection 2021.
Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in select immunocompromised hosts are not clear. We provide clinical, immunological, virological, and histological data on a cohort of 28 patients with a broad spectrum of IEI and RuV-associated granulomas in skin and nine extracutaneous tissues to further delineate this relationship. Combined immunodeficiency was the most frequent diagnosis (67.8%) among patients. Patients with previously undocumented conditions, i.e., humoral immunodeficiencies, a secondary immunodeficiency, and a defect of innate immunity were identified as being susceptible to RuV-associated granulomas. Hematopoietic cell transplantation was the most successful treatment in this case series resulting in granuloma resolution; steroids, and TNF-α and IL-1R inhibitors were moderately effective. In addition to M2 macrophages, neutrophils were identified by immunohistochemical analysis as a novel cell type infected with RuV. Four patterns of RuV-associated granulomatous inflammation were classified based on the structural organization of granulomas and identity and location of cell types harboring RuV antigen. Identification of conditions that increase susceptibility to RuV-associated granulomas combined with structural characterization of the granulomas may lead to a better understanding of the pathogenesis of RuV-associated granulomas and discover new targets for therapeutic interventions.
风疹病毒(RuV)最近在伴有先天免疫缺陷(IEI)患者皮肤和多种内脏器官肉芽肿性炎症的患者中被发现。RuV 在特定免疫功能低下宿主中持续存在和发病的细胞嗜性和分子机制尚不清楚。我们提供了一组 28 例具有广泛 IEI 和皮肤及 9 种皮肤外组织中与 RuV 相关的肉芽肿患者的临床、免疫学、病毒学和组织学数据,以进一步阐明这种关系。联合免疫缺陷是患者中最常见的诊断(67.8%)。具有先前未记录的疾病,即体液免疫缺陷、继发性免疫缺陷和先天免疫缺陷的患者易发生与 RuV 相关的肉芽肿。造血细胞移植是该病例系列中最成功的治疗方法,导致肉芽肿消退;皮质类固醇、TNF-α 和 IL-1R 抑制剂具有中等疗效。除 M2 巨噬细胞外,免疫组织化学分析还鉴定出中性粒细胞是一种新型感染 RuV 的细胞类型。根据肉芽肿的结构组织和携带 RuV 抗原的细胞类型的身份和位置,将与 RuV 相关的肉芽肿性炎症分为四种模式。鉴定增加与 RuV 相关的肉芽肿易感性的条件,并对肉芽肿进行结构特征分析,可能有助于更好地了解与 RuV 相关的肉芽肿的发病机制,并发现治疗干预的新靶点。